Traynor Capital Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-15,380
Closed -$105K 221
2022
Q3
$105K Sell
15,380
-1,172
-7% -$8.14K 0.02% 161
2022
Q2
$138K Buy
16,552
+3,375
+26% +$47.2K 0.02% 154
2022
Q1
$301K Buy
+13,177
New +$322K 0.04% 135
2018
Q1
Sell
-10,251
Closed -$213K 175
2017
Q4
$213K Buy
+10,251
New +$163K 0.09% 156

Other funds holding BHC

Traynor Capital Management's BHC Position: Q4 2022 in Review

Traynor Capital Management sold out of Bausch Health (BHC) in Q4 2022, closing a stake of 15,380 shares — an estimated $105K sold.

Traynor Capital Management first reported a position in BHC in Q4 2017 and held it in 4 quarters. The position peaked at $301K in Q1 2022. 262 funds tracked by Wall St. Rank hold BHC as of Q4 2022.

  • Traynor Capital Management reported no remaining Bausch Health position as of Q4 2022 after selling out during the quarter.
  • Traynor Capital Management sold 15,380 Bausch Health shares in Q4 2022, an estimated $105K.
  • Traynor Capital Management first reported a position in Bausch Health in Q4 2017 and held it in 4 quarters.
  • Traynor Capital Management's Bausch Health position peaked at $301K in Q1 2022.
  • 262 funds tracked by Wall St. Rank held Bausch Health as of Q4 2022.

Based on Traynor Capital Management's 13F filing for Q4 2022, filed 27 Jan 2023.